Patent details

EP3221465 Title: QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS

Basic Information

Publication number:
EP3221465
PCT Application Number:
US2015061684
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158023267
PCT Publication Number:
WO2016081770
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
QUANTITATION OF GLYCAN MOIETY IN RECOMBINANT GLYCOPROTEINS
French Title of Invention:
QUANTIFICATION DE LA FRACTION GLYCANE DANS DES GLYCOPROTÉINES RECOMBINANTES
German Title of Invention:
QUANTIFIZIERUNG EINES GLYCANTEILS IN REKOMBINANTEN GLYKOPROTEINEN
SPC Number:

Dates

Filing date:
19/11/2015
Grant date:
13/03/2019
EP Publication Date:
27/09/2017
PCT Publication Date:
26/05/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/03/2019
EP B1 Publication Date:
13/03/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/11/2019
Expiration date:
19/11/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/03/2019
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Inventor

Name:
CHEMMALIL, Letha
Address:
United States (US)

Priority

Priority Number:
201462082014 P
Priority Date:
19/11/2014
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/37; G01N 21/47; G01N 33/66;

Publication

European Patent Bulletin

Issue number:
201911
Publication date:
13/03/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages